Meiling Zhan

Statistics

Publications

Citations

137

H-Index

Active since

2022

Affiliations

China Pharmaceutical University(Current)

Meiling Zhan is an author at China Pharmaceutical University specializing in metabolic modulation, glycolysis, and cardiovascular molecular physiology.

Publications per year

2022–2023

Publications

Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response

Hao Zeng, Ting Pan, Meiling Zhan et al. · Signal Transduction and Targeted Therapy · 2022 · 112 citations · Full text

Life Sciences, Cardiology, Cell Biology +17

Salvianolic acid A diminishes <scp>LDHA</scp>‐driven aerobic glycolysis to restrain myofibroblasts activation and cardiac fibrosis via blocking Akt/<scp>GSK</scp>‐3β/<scp>HIF</scp>‐1α axis

Renaguli Hailiwu, Hao Zeng, Meiling Zhan et al. · Phytotherapy Research · 2023 · 25 citations · Full text

Medicine, Biochemistry, Pharmacology +14

1–2 of 2